1. Tao, Chang, Liu, Wang, Yan, Xiang, Li, Benyi, Zhu, Runzhi. 2022. PAQR5 Expression Is Suppressed by TGFβ1 and Associated With a Poor Survival Outcome in Renal Clear Cell Carcinoma. In Frontiers in oncology, 11, 827344. doi:10.3389/fonc.2021.827344. https://pubmed.ncbi.nlm.nih.gov/35127538/
2. Lu, Tao, Xu, Hai-Rong, Dong, Wei, Dong, Hui. 2022. Expression and prognosis analysis of PAQR5 in kidney cancer. In Frontiers in oncology, 12, 955510. doi:10.3389/fonc.2022.955510. https://pubmed.ncbi.nlm.nih.gov/36119517/
3. Wang, Lu, Yue, Yangyang, Zhang, Lu, Fan, Jinhai, Zhang, Mengzhao. 2023. PAQR5 inhibits the growth and metastasis of clear cell renal cell carcinoma by suppressing the JAK/STAT3 signaling pathway. In Cellular oncology (Dordrecht, Netherlands), 46, 1317-1332. doi:10.1007/s13402-023-00813-w. https://pubmed.ncbi.nlm.nih.gov/37126128/
4. Sinreih, Maša, Knific, Tamara, Thomas, Peter, Frković Grazio, Snježana, Rižner, Tea Lanišnik. 2018. Membrane progesterone receptors β and γ have potential as prognostic biomarkers of endometrial cancer. In The Journal of steroid biochemistry and molecular biology, 178, 303-311. doi:10.1016/j.jsbmb.2018.01.011. https://pubmed.ncbi.nlm.nih.gov/29353001/
5. Aljabban, Jihad, Rohr, Michael, Borkowski, Vincent J, Hadley, Dexter, Panahiazar, Maryam. 2022. Probing predilection to Crohn's disease and Crohn's disease flares: A crowd-sourced bioinformatics approach. In Journal of pathology informatics, 13, 100094. doi:10.1016/j.jpi.2022.100094. https://pubmed.ncbi.nlm.nih.gov/36268056/
智鼠故事 
